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Abstract    492 words 

Objective To carry out a systematic review of the relationship between total fat intake and body weight in adults and children utilising all relevant randomised controlled trials (RCTs) and cohort studies. 
Design Data were extracted and validity assessed independently in duplicate.  Random effects meta-analyses, sub-grouping, sensitivity analyses and meta-regression were performed.  
Data sources. We searched Medline, EMBASE, CINAHL and Cochrane CENTRAL in two independent searches to June 2010.
Eligibility criteria for selecting studies. We included RCTs and cohort studies of adults or children that compared lower vs. usual total fat intake and assessed effects on measures of body fat (body weight, body mass index (BMI), body fatness or waist circumference) after at least 6 months (in RCTs) or 1 year (in cohorts).  RCTs with any intention to reduce weight in participants or confounded by additional medical or lifestyle interventions were excluded.
Results. 33 RCTs (73,589 participants) and 10 cohort studies in adults were included, all from North America, Europe or New Zealand.  Meta-analysis of RCT data suggested that diets lower in total fat are associated with lower relative body weight (by 1.6kg, 95% CI -2.0 to -1.2kg, I2 75%, 57735 participants).  Lower weight gain in the low fat arm than the control arm was consistent across RCTs, but the size of the effect varied.  Meta-regression suggested that greater total fat reduction and lower baseline fat intake were associated with greater relative weight loss, explaining most of the heterogeneity.  The statistically significant effect of low fat diet on weight was not lost in sensitivity analyses (including removing  RCTs that expended greater time and attention on low fat groups).  Lower total fat intake also lead to lower body mass index (BMI, -0.51 kg/m2, 95% CI -0.76, -0.26, 9 trials, I2 77%) and waist circumference (by 0.3cm, 95% CI -0.58 to -0.02, 15671 women, 1 RCT).  There was no suggestion of negative effects on other cardiovascular risk factors (lipids or blood pressure).  GRADE assessment suggested that the quality of evidence for the relationship between total fat intake and weight in adults was high.  Only 1 RCT and 3 cohort studies were found in children, but these confirmed a positive relationship between total fat intake and weight gain.
Conclusions.  There is high quality, consistent evidence that total fat reduction has been achieved in large numbers of both healthy and “at risk” trial participants over many years, and leads to small but statistically significant and clinically meaningful, sustained reductions in body weight in adults in studies with baseline fat intakes of 28 to 43% of energy intake and durations from 6 months to over 8 years.  There is supporting evidence for a similar effect in children. 

Systematic review registration.  The protocol for this review was agreed in outline at the 1st meeting of the WHO Nutrition Guidance Expert Advisory Group (NUGAG) Subgroup on Diet and Health convened in February 2010, but is not published.  Ethical approval was not sought as it is not required for systematic reviews.


What this paper adds

What is already known
The ideal proportion of total fat in the human diet is unclear.  In assessing this proportion an understanding of the relationship between total fat and body weight would be helpful.  Two previous systematic reviews addressed this issue in adults but included studies of very short duration, and studies which encouraged weight reduction in participants, and so they may have overstated any relationship. No systematic reviews have assessed the relationship in children.
What this study adds






The optimal intake of total fat was debated at the Joint Food and Agriculture Organization of the United Nations/ World Health Organization (FAO/WHO) Expert Consultation on fats and fatty acids in human nutrition held in November 2008, and it was agreed that any effect of total fat intake on body weight was crucial to making global recommendations (in the context of increasing overweight and obesity, in particular in low and middle income countries undergoing rapid nutrition transition). Overweight and obesity increase the risk of many cancers, coronary heart disease and stroke  ADDIN REFMGR.CITE (1-3).  
While a previous systematic review found no randomized controlled trials (RCTs) of reduced total fat intake that aimed to assess effects on weight (4), meta-regression within a systematic review that assessed RCTs of the effects of Step I and II diets, found a strong relationship between total fat intake and weight (5).  However this latter review included studies as short as 3 weeks duration and studies in which weight loss was a goal of the intervention, which may have overstated any relationship because advice was to lower both fat and energy intake, and excluded many trials of total fat reduction that did not fit the Step I or II criteria.  

To understand the relationship between total fat intake and body weight WHO requested the WHO Nutrition Guidance Expert Advisory Group (NUGAG) Subgroup on Diet and Health  (www.who.int/nutrition/topics/NUGAG_meeting/en/index.html) to assess the relationship with a view to updating WHO guidelines on total fat intake.  In order to fulfill the requirements of the new WHO guideline development process, systematic review of all available evidence of longer term effects of total fat on body fatness, in studies not intending that participants lose weight, was needed. WHO, therefore, commissioned a systematic review and meta-analysis to assess the relationship between total fat intake and indicators of body fatness (including obesity, body fatness, waist circumference or BMI) using all appropriate RCTs and cohort studies in adults and children.  NUGAG’s aim was to generate a recommendation regarding the population impact of total fat in obesity development.  They agreed that “populations” recruited specifically for weight loss studies and interventions intended to result in weight loss would be excluded as they were potentially confounded by the implicit objective of reducing calorie intake in order to produce weight loss, and would lead to an overemphasis on studies conducted in highly selected obese populations in North America and Europe which may have limited application to non-obese populations or those in developing countries, or countries in transition.   

Methods
Methods of the Cochrane Collaboration were followed, with a view to development of WHO guidance according to the WHO guideline development process (6;7).

Inclusion criteria
We included randomised controlled trials (RCTs) and prospective cohort studies in apparently healthy children or adults from any country.  RCTs had to compare an intervention intended to reduce total fat intake by reducing percentage energy from fat or total fat in g/d with a “usual fat intake” arm and continue the intervention for at least 26 weeks. The intervention could include dietary advice and/or provision of foods or whole diet, but should not be confounded by effects of other lifestyle or medical interventions. Studies where a low fat diet was compared to usual diet were included, or low fat diet plus any non-dietary intervention vs. usual diet plus the same non-dietary intervention, but low fat diet plus any non-dietary intervention vs. usual diet alone was not included. Interventions where weight loss was intended (in either or both arms, or in any proportion of participants) were excluded.  Some measure of body fatness (body weight, BMI, body fatness and/or waist circumference) had to be assessed as change from baseline or at study end.  Cohort studies had to assess the relationship between total fat intake at baseline and change in a measure of body fatness from baseline over at least 1 year, or body fatness at least a year later. 
Searching / study identification
Two independent searches were run.  A search for adult RCTs was carried out on Medline, EMBASE (both on OvidSP), and the Cochrane Library CENTRAL database to June 2010 (see Supplementary Table 1a (8)). The other search was carried out on Medline, EMBASE and CINAHL to June 2010 to identify adult and child RCTs and cohort studies (see Supplementary Table 1b (9)).  Neither search was limited by language. The bibliography of a related systematic review (10) was checked for further trials.  Members of the NUGAG Subgroup on Diet and Health were also asked for relevant local studies and official letters were sent from WHO through their six Regional Offices to Member States to solicit relevant studies carried out in their countries. 

Study assessment
The process of assessing titles and abstracts, collecting and assessing inclusion of full text papers (each independently in duplicate) was carried out independently for each search.  Data extraction and study validity assessment were carried out independently in duplicate, and differences between reviewers' results were resolved by discussion and, if necessary, in consultation with a third reviewer.  The reviewers attempted to contact authors of RCTs to retrieve missing data on study validity, but not on outcome data or for cohort studies due to time limitations.
.
For RCTs, data concerning participants, interventions, outcomes (body weight, BMI, body fat and waist circumference) and trial quality characteristics were extracted. Data were also collected, where possible, on potential effect modifiers including: health status; cardiovascular risk; age; gender; country; baseline BMI; mean years in trial; number randomised and analysed; type of comparison; total and saturated fat intake during intervention period; energy, carbohydrate, sugar, protein and alcohol intake; baseline total fat intake; information on intention to treat analyses (ITT); and difference in total fat intake (as a percentage of energy, %E) between RCT arms at latest time point. For dichotomous outcomes, numbers of participants experiencing an outcome, and total numbers of participants randomised, were extracted for each randomised arm. For continuous outcomes number of participants assessed, means and standard deviations of the change in, or final readings of, each treatment arm were extracted (where both change data and final readings were available change data were used). Data were extracted at the latest time point within the following: 6 to <12 months, 12 to <24 months, 24 to <60 months, 60+ months.

For cohort studies data on setting, design, measurement of the exposure to total fat, participant characteristics, similarity at baseline between high and low fat exposure groups, participant flow and endpoint criteria were collected.  Any assessment of relationship of the outcome (body weight, BMI, body fat or waist circumference) with total fat intake, and the most adjusted and any non-energy-adjusted assessments were collected. 

Assessment of validity
Cochrane criteria (6) were used to examine validity of RCTs, including sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, incomplete outcome data and selective outcome reporting. Additional review-specific criteria included presence or not of dietary interventions over and above alteration of total dietary fat, and similarity or not of type and intensity of intervention in both arms.

For cohort studies the criteria were based on the Newcastle-Ottawa criteria (11) after consideration of the crucial criteria for this review. They included whether the design used an internal or external control group; number lost to follow up; baseline similarity of the most and least exposed groups; factors adjusted for in analysis; and method of assessment of total fat intake. Moderate risk of bias was suggested where <20% were lost to follow up, up to 2 major factors were unadjusted for in the design or analysis, and diet was assessed using a 24-hour recall or diet diary: all other studies were at high risk of bias. 

Data Analysis
Results were considered statistically significant where p<0.05.  For RCTs, data were combined by the inverse variance method in random effects meta-analysis on Review Manager software (RevMan5 (12)) to assess mean differences in outcome between lower and higher fat intake arms. Where there was more than one relevant intervention arm but only one control arm the relevant intervention arms were pooled to create a single pair-wise comparison (6). Intervention arms not appropriate for this review, or less appropriate than another arm, were excluded. When two arms were appropriate for different subgroups then the control group was used once with each intervention arm, but the subgroups were not pooled overall. When outcomes were assessed at more than one time point, data from the latest time point available were used in general analyses, but all relevant time points were used in subgrouping by study duration.  Heterogeneity was examined using the I2 test, and considered important where >50% (6;13). Funnel plots were drawn to examine the possibility of publication bias  ADDIN REFMGR.CITE (14;15).

Pre-specified subgroups included: mean follow-up time; difference in fat intake between intervention and control groups (dose effect, ‘difference of up to 5% of energy from fat’, ‘>5% to 10%’, ‘>10% to 15%’ and ‘>15%’); control group total fat intake; year of first publication of results, and gender.  Following discussion of preliminary results with the NUGAG Subgroup on Diet and Health at its 2nd meeting in March 2011 the following subgroupings were added for adult RCTs: by difference in the level of attention given to intervention and control participants; total fat %E goal in intervention arm; intervention resulted in more or less than 30%E from fat; and baseline BMI (mean BMI <25, ≥ 25 to 29.9 and ≥ 30 kg/m2). A difference in the level of attention given to the intervention and control groups meant any variation, including any difference in the amount of health professional or training time or number or timing or duration of follow-ups.  Journal referees requested that subgrouping was added by health status (healthy people not recruited on the basis of health status, those with risk factors such as raised lipids or breast cancer risk, and current illness such as diabetes, coronary heart disease, cancer or polyps) and by degree of energy reduction in the low fat group compared to the control or usual fat group.  The NUGAG Subgroup on Diet and Health also requested meta-regression, which was run in STATA/IC 11.2 to assess effects of study duration, amount of reduction in total fat in the intervention arm compared to the control arm (as %E), and control group fat intake as the subgrouping suggested that these factors may relate to degree of weight loss (multiple regression model, all 3 assessed together).  Finally, the NUGAG Subgroup on Diet and Health requested serum lipid and blood pressure outcome data be collected from the included adult RCTs to ensure that fat reduction was not associated with harmful effects on other major cardiovascular risk factors, and data on changes in other dietary components be collated to help with understanding any mechanisms of action.

Sensitivity analyses assessed effects of running fixed effects meta-analyses and excluding: the largest RCT; RCTs not free of systematic differences in care (or unclear); RCTs not free of dietary differences other than fat (or unclear); RCTs without or with unclear allocation concealment (an important indicator of study validity); RCTs using ITT analyses. 

We intended to use meta-analysis on the results of cohort studies where feasible, but given the small number of included cohorts and differences between studies in duration, measures of body fatness and assessment methods of correlation between total fat intake and outcomes, meta-analysis was not appropriate.  Instead, vote-counting was used to describe the relationship between total fat intake and body fatness in each study.  A positive and statistically significant relationship between total fat intake at baseline and change in outcome was marked “+”, a negative and statistically significant relationship between total fat intake at baseline and change in outcome was marked “-”, and a non-statistically significant relationship between total fat intake at baseline and change in weight or BMI over time was marked “0”.  





Searches for adult RCTs identified 22,012 titles and abstracts for assessment of inclusion, while the search for adult and child RCTs and cohort studies identified 10,208 potential titles and abstracts.  The flow of assessment is shown in Figure 1.  Overall 465 full text studies were assessed for inclusion, and 33 adult RCTs, 1 child RCT, 10 prospective cohort studies in adults and 3 in children were included. 

Figure 1: flow diagram of electronic search strategies* 








Table 1. Brief characteristics of included adult RCTs

Trial	Participants	Intervention aims 	Control aims 	Duration (years)*, country 
Aukland reduced fat 1999 (18)	176 adults with impaired glucose tolerance 	reduced fat diet (no specific goal)	usual diet	4.1,  New Zealand
BDIT Pilot Studies 1996 (19) 	295 Women with mammographic dysplasia	total fat 15%E, replace fat by complex CHO	healthy diet (no fat advice)	6.8 int, 7.5 cont,Canada
beFIT 1997   ADDIN REFMGR.CITE (20-22)	409 people with mild hyper-cholesterolaemia	total fat <30%E, SFA <7%E, dietary chol<200mg/d	delayed dietary changes 	Unclear (max 0.5),USA
Bloemberg 1991  (23)	80 Men with untreated raised total cholesterol	30%E from fat, PUFA/SFA 1.0, chol 20mg/MJ.	usual diet	0.5, Netherlands
BRIDGES 2001 (24)	106 Women with recent stage I or II breast cancer	total fat 20%E, high fibre, plant based 	no formal intervention	? (1 max),USA
Canadian DBCP 1997 (25)	896+ Women with mammographic densities >50% 	total fat 15%E, protein 20%E, CHO 65%E, isocaloric	usual diet	2.0,Canada
CARMEN 2000   ADDIN REFMGR.CITE (26;27)	153 Healthy people, BMI 26-34	fat reduced by 10%E, increased simple/complex CHO	attain national "normal" intake	? (max 0.5), Europe
CARMEN MS sub-study 2002  (26)	22 People with at least 3 risk factors for metabolic syndrome	as CARMEN	as CARMEN	0.5 int, 0.4 cont., as CARMEN
de Bont 1981 (28) 	148 Women with type 2 diabetes	fat 30%E, reducing meat fat, dairy foods, improve SFA/PUFA ratio, CHO increased	usual diet with CHO ≤ 40%E	0.5, UK
DEER 1998  (29)	197 Men and 180 Post-menopausal women with raised LDL & low HDL cholesterol	NCEP step 2 diet: <30%E fat, <7%E SFA, <200mg/d chol	usual diet 	1.0, USA
German Fat Reduced 1996  (30)	70 Women with BMI 24-29	buy low fat foods from trial shop	buy usual fat foods from trial shop	0.8 int, 0.7 cont, Germany
Kentucky Low Fat 1990  (31;32)	118 Moderately hyper-cholesterolaemic, non-obese Caucasians	25%E from fats, 20%E from protein, 55%E from CHO, <200mg chol /day	no diet intervention	0.9, USA
Kuopio 1993  (33)	159 Free-living people with serum total cholesterol 6.5-8.0mmol/L	AHA: total fat 30%E, SFA <10%E, MUFA 10%E, PUFA 10%E low fat: total fat 28-30%E, SFA <14%E, MUFA 10%E, PUFA 4%E	Mono: fat 38%E, SFA <14%E, MUFA 18%E, PUFA <6%Econt: fat 38%E, SFA <18%E, MUFA 15%E, PUFA <5%E	0.5, Finland
Mastopathy Diet 1988 (34)	21 Women with severe cyclical mastopathy	total fat 15%E, CHO 65%E	healthy diet, no fat advice	0.45, Canada
MeDiet 2006(35) 	115 Healthy post-menopausal women with high testosterone	Sicilian diet (reduced total, SFA & omega-6 fats, increased fish, whole cereals, legumes, seeds, fruit & veg)	increase fruit & veg intake	4.3, Italy
Moy 2001  (36)	267 siblings of people with early CHD, with ≥1 CVD risk factor	nurse management, aim total fat ≤40g/d	physician risk management	1.9, USA
MSFAT 1995 (37)	240 Healthy people aged 20-55	trial shop low fat products ad lib.	trial shop usual fat products ad lib.	0.5, Netherlands
NDHS Open 1st & 2nd 1968 (38) 	821 Free living men	B: fat 30%E, SFA <9%E, chol 400mg/d, PUFA 15%E, P/S 1.5X: fat 30%E, SFA <9%E, chol 400mg/d, PUFA 15%E, P/S 1.5	fat 40%E, SFA 16-18%E, chol 700mg/d, P/S 0.4	0.9, USA
NDHS Open 2nd 1968  (38)	498 Free living men	BC fat 30-40%E, SFA reduced, dietary chol 400 mg/d, P/S 1.5-2.0	fat 40%E, SFA 16-18%E, chol 700mg/d, P/S 0.4	0.6, USA
Nutrition & Breast Health (39)	122 Pre-menopausal women at increased risk of breast cancer	total fat 15%E 	daily food guide pyramid 	0.8 int, 1.0 cont, USA
Pilkington 1960  (40)	35 Men with angina or who have had an MI	fat 20g/d, avoid dairy except skimmed milk & 1 egg or 21g cheese/d. Lean meat & fish each 1/d, CHO unlimited	 fat aims ?, only skimmed milk, 90ml/d soya oil, lean meat, unsat margarine	1.1, UK
Polyp Prevention 1996   ADDIN REFMGR.CITE (41;42)	2079 People with ≥1 large bowel polyps	fat 20%E, 18g fibre/1000kcal, 5-8 servings/d fruit & veg	general dietary guidelines	3.1, USA
Rivellese 1994  (43)	63 Adults with primary hyperlipoproteinaemia	fat 25%E, SFA 8%E, MUFA 15%, PUFA 2%, chol <300mg/d, CHO 58%	fat 38%E, SFA <10%E, MUFA 20%E, PUFA 10%E, chol <300 mg/d, CHO 47%E	0.4, Italy
Simon Low Fat Breast CA (44)	194 women with high risk of breast cancer	total fat 15%E	usual diet	1.7 int, 1.8 cont, USA
Sondergaard 2003 (45)	115 people with IHD plus total cholesterol ≥5mmol/L	fat & SFA reduced, replace fats with oils, 600g fruit & veg/d, fatty fish ≥1/wk, CHO freely	unclear	1.0, Denmark
Strychar 2009  (46)	30 people with well controlled type I diabetes mellitus	fat 27-30%E, SFA ≤10%E, MUFA 10%, CHO 54-57% 	fat 38%E, SFA ≤10%E, MUFA 20%E, CHO 45%E	0.5, Canada
Swedish Breast CA 1990   ADDIN REFMGR.CITE (47-49)	169 women after breast cancer surgery	fat 20-25%E, replace energy with CHO 	usual diet	1.5 int, 1.9 cont, Sweden
Veterans Dermatology 1994  (50)	115 people with non-melanoma skin cancer	fat 20%E, protein 15%E, CHO 65%E	no dietary advice	1.9, USA
WHEL 2007 (51)	3088 women with treated early breast cancer 	fat 15-20%E, increase fruit and veg plus 16 oz veg juice	fat 30%E  	11, USA
WHI 2006  (52)	48835 post-menopausal women	fat 20%E with increased fruit & veg and grains	unclear, diet-related education	8.1, USA
WHT Feasibility 1990 (53)	261 women at risk of breast cancer 	fat 20%E 	usual diet	1.9, USA
WHT:FSMP 2003 (53)	1720 post-menopausal women, diverse ethnic & socio-economic status	fat ≤20%E, reduced SFA & chol, increased fruit, veg, wholegrains 	usual diet	? (1.5 max),  USA
WINS 1993 (54)	2437 women with re-sected breast cancer 	fat 15-20%E	nutritional adequacy	5.0, USA
* mean years in trial (not maximal duration)
Abbreviations: ? = unclear, CHO = carbohydrates, Chol = dietary cholesterol, %E = percentage of total energy intake, P/S = polyunsaturated / saturated fat ratio, CVD = cardiovascular disease, CHD = coronary heart disease, MUFA = mono-unsaturated fat, PUFA = polyunsaturated fat, SFA = saturated fat, IHD = ischaemic heart disease


Risk of bias was variable.  Randomisation was generally adequate, but allocation concealment (which may be an important predictor of study bias) was unclear in over half of RCTs (Figure 2, further details in Supplementary Figure 1).  Included RCTs scored poorly for blinding, but this is not surprising with a dietary intervention of this type – fat intake can only really be blinded in very well conducted institutional and/or food provision by study shop trials. RCTs generally appeared free of other types of bias and of selective reporting.  A third of RCTs were free of systematic differences in care, support, time and/or attention between intervention and control arms, and three quarters were free of dietary changes or advice additional to the change in fat intake.





Effects of reducing fat on weight













The main analysis was of all included RCTs with weight data, assessing the effect of reduction in total fat compared to usual fat intake on weight at the latest time point.  Meta-analysis suggested that the mean effect of reduction in total fat was weight loss of 1.57kg (95% CI -1.97 to -1.16, I2 75%, 57735 participants) in the lower fat group relative to control (Figure 3).  In some cases this relative reduction in weight was due to a smaller rise in weight over time in the intervention group than in the control; in some trials there was weight reduction in the low fat group, but weight gain in the control; and in other RCTs there was greater weight reduction in the low fat group than the control.  The I2 of 75% suggests that although the RCTs are remarkably consistent in suggesting lower weight in low fat compared to control (see Figure 3, almost all RCTs have the best estimate of effect on weight on the left side of the vertical line), there was heterogeneity in the amount of that weight reduction.   The funnel plot showed that more than 5% of studies fell outside the 95% confidence lines, but some of this was explained by baseline total fat intake subgrouping (15), so that the scope for distortion of results by publication bias or outcome reporting bias was limited , see Supplementary Figure 2.  

Seven of the eight RCTs which could not be pooled concurred in having greater weight reduction in low fat arms than control arms (see the seven “not estimable” studies in Figure 3) ADDIN REFMGR.CITE (20-22;34;35;38;43;50), the exception was Sondergaard 2003 (45) which reported “in both groups, body weight remained unchanged after 12 months” and was not detailed enough to be shown in the forest plot.  We examined the possible presence of reporting bias using the list of included studies from a recent review of RCTs of reduced and modified fat on cardiovascular events (8). Of 48 included RCTs in the other review, 24 studies were included in the current review.  Of the remaining 24 RCTs, 10 did not assess a reduced vs. usual fat comparison (they were included as they modified fat) ADDIN REFMGR.CITE (55-65), and 13 aimed to reduce weight in some or all participants so were ineligible for the current review   ADDIN REFMGR.CITE (66-78).    Only one trial was eligible for this review but had not been included as no data were provided on weight, BMI or waist circumference (79).  The risk of reporting bias, related to the proportion of studies not included in a meta-analysis, appears minimal here (80).

We explored reasons for the observed heterogeneity in effect size using subgrouping.  Figure 3 demonstrates the relationship between exposure dose and outcome, with RCTs categorised with respect to the change in percentage fat intake between the intervention and control groups.  Where total fat intake differed by more than 5% of energy (5%E) between intervention and control arms there were statistically significant reductions in weight in the lower fat arm compared to the usual fat arm.  The size of the effect of reducing total fat on weight did not differ substantially by participant gender, by decade of first publication of results, dietary fat goal in the intervention group, by whether the intervention fat level was below or above 30% of energy, by baseline BMI, or by health status at baseline(see Table 2).  There was a suggestion from subgrouping that effects on weight were reduced in RCTs of longer duration (over 5 years, p=0.03 for subgroup differences), greater in those with lower baseline fat intake (p<0.00001 for subgroup differences), and with greater reduction in fat in the intervention group compared to the control (p=0.002 for subgroup differences).  

Meta-regression (multiple regression model on all 3 factors at once) suggested that the degree of fat reduction was statistically significantly associated with degree of weight loss in the intervention arm compared to control (coefficient -0.19kg /1%E from total fat reduction, 95% CI -0.33 to -0.06, p=0.006), suggesting that greater fat reduction is associated with greater weight loss.  Control group fat intake (equivalent to baseline fat intake) was also statistically significantly associated with the degree of weight loss in the intervention group (coefficient 0.16kg/1%E from fat in the control group, 95% CI 0.05 to 0.27, p=0.008), suggesting that fat reduction is more effective at reducing weight in those with lower baseline fat intake, There was no clear association between RCT duration and degree of weight loss (coefficient 0.01kg/month, 95% CI -0.004 to 0.029, p=0.14).  Together these factors explained 58% of between-study variance, and the full equation was: Weight change, kg = -5.77kg + 0.16kg/1%E total fat in control group -0.19kg/1%E fall in total fat in intervention group +0.01kg/month duration.


Table 2.  Sub-grouping of results from adult RCTs 
Subgrouping factor	Group 	Effect size in kg (95% CI)	No. of comparisons, I2
Overall analysis	all RCT arms	-1.57kg (-1.97 to -1.16)	27, 75%
RCT duration, months	6 to <12	-1.75kg (-2.28 to -1.22)	13, 63%
	12 to <24	-2.00kg (-2.51 to -1.48)	17, 71%
	24 to <60	-1.18kg (-1.65 to -0.70)	9, 56%
	60+ 	-0.68kg (-1.66 to 0.29)	4, 58%
Control group fat intake, as % energy intake	>35	-1.20kg (-1.62 to -0.78)	11, 64%
	>30 to 35	-1.06kg (-1.96 to -0.17)	10, 69%
	>25 to 30	-2.97kg (-3.60 to -2.33)	5, 1%
Participant gender	all men	-2.74kg (-4.32 to -1.17)	4, 76%
	all women	-1.42kg (-1.93 to -0.92)	16, 70%
	mixed	-1.27kg, (-2.08 to -0.47)	7, 75%
Publication decade	1960s	-4.10kg (-8.06 to -0.14)	1
	1970s	No RCTs	
	1980s	-0.91kg (-1.80 to -0.01)	3, 0%
	1990s	-1.94kg (-2.57 to -1.31)	16, 77%
	2000s	-0.95kg (-1.57 to -0.33)	7, 72%
Fat goal in intervention group	35+%E 	No data	
	30-<35%E 	-0.96kg (-1.66 to -0.26)	3, 0%
	25-<30%E 	-2.39kg (-3.82 to -0.97)	6, 87%
	20-<25%E 	-0.85kg (-1.13 to -0.57)	6, 14%
	15-<20%E 	-1.28kg (-2.19 to -0.37)	7, 58%
Difference in fat intake between intervention & control	Up to 5%E	-0.19kg (-0.88 to 0.50)	6, 19%
	5 to <10%E	-2.08kg (-2.77 to -1.39)	13, 82%
	10 to <15%E	-1.34kg (-1.70 to -0.98)	4, 26%
	15+%E	-3.89kg (-8.76 to 0.99)	3, 68%
Fat in intervention (control  >30%E)	>30%E 	-0.83kg (-1.29 to -0.38)	6, 0%
	≤30%E 	-1.20kg (-1.69 to -0.72)	15, 74%
Baseline BMI	<25	-0.96kg (-1.69 to -0.22)	8, 56%
	25 to <30	-1.82kg (-2.37 to -1.28)	16, 82%
	≥30	-2.06kg (-2.96 to -1.17)	2, 0%
Baseline health status	Healthy	-0.98kg (-1.56 to -0.41)	3, 87%
	With risk factors	-2.11kg (-2.93 to -1.29)	15, 74%
	With an illness	-1.20kg (-1.85 to -0.56)	9, 44%
Energy intake in reduced fat group compared to control	The same or greater 	-0.51kg (-1.49 to 0.49)	4, 25%
	1 to 100 kcal/d lower 	-1.49kg (-2.92 to -0.06)	4, 66%
	101 to 200 kcal/d lower	-1.14kg (-2.24 to -0.04)	5, 80%




A feasible explanation for the relative weight reduction in lower fat arms might be that the intervention (low fat) participants received more time, attention and/or support than those in the control arms, so that the weight loss was due to factors other than the fat content of the diet.  To assess this we ran a sensitivity analysis removing RCTs with different levels of attention or support to the low fat arms (leaving RCTs that worked to attain specific fat goals in the control group and RCTs conducted in institutions or through trial shops).  A statistically significantly greater weight reduction in the lower fat arms (of -1.4kg) remained (see Table 3).  We also wondered whether other concomitant dietary interventions (such as encouragement to eat more fruit and vegetables in the low fat arms of some RCTs) may have been responsible for the weight effect.  When we removed the RCTs with dietary advice additional to the low fat advice again the reduced weight in the low fat groups remained (Table 3).  As sensitivity analyses we also re-ran our analyses using fixed effect meta-analyses, excluding the largest RCT (WHI), and excluding RCTs with unclear or no allocation concealment, and in all cases the results were consistent in suggesting that reducing total fat intake results in a small but statistically significant reduction in weight compared with usual fat intake.  As no RCTs had used ITT analysis the relevant sensitivity analysis was omitted. 


Effect of fat on BMI and waist circumference




Table 3. Sensitivity analyses of adult RCTs assessing effect of dietary fat intake on weight (kg).
Sensitivity analysis	Effect size in kg (95% CI)	No. of comparisons, I2
Removing RCTs with more attention to low fat arm	-1.42kg (-2.12 to -0.73)	8, 38%
Removing RCTs with dietary interventions additional to fat	-1.90kg (-2.49 to -1.31)	22, 69%
Meta-analysis using fixed effects analysis	-1.04kg (-1.18 to -0.90)	27, 74%
Excluding the single largest RCT (WHI)	-1.65kg (-2.10 to -1.21)	26, 69%
Excluding RCTs without or with unclear allocation concealment	-1.10kg (-1.56 to -0.65)	13, 59%


Effect of fat on serum lipids and blood pressure
The effects of low fat intervention on serum lipids and blood pressure were meta-analysed, and appeared positive (statistically significantly protective) for LDL and total cholesterol, total/HDL ratio, systolic and diastolic blood pressure (Supplementary Table 3).  The effect on HDL cholesterol was negative (of borderline statistical significance), and there was no clear effect on triglycerides.  

Effect of reducing fat on intake of energy, carbohydrate, sugars, protein and alcohol





Ten cohort studies were found in adult populations, including 107,624 participants over 665,756 person-years, the majority based in the United States (7 studies), two in Denmark, one from Sweden. Participants were from various ethnic groups, male and female and aged 18 to 80 years.  Results were stratified in different studies by ethnicity (Black, Caucasian, Hispanic), gender, age and level of activity.  Characteristics of the included cohort studies are shown in Supplementary Table 5, and validity in Supplementary Table 6.  According to our pre-specified definition one study was at moderate risk of bias and the others were at high risk.  


Relationship between baseline total fat intake and change in body fatness.
 Of 16 assessments of the effects of total fat intake on subsequent weight change in seven cohorts, 11 showed no statistically significant effect, while five (31%) showed a statistically significant positive effect. Eight assessments included at least 1000 participants, and of these three (38%) suggested a statistically significant positive relationship. Ten assessed the relationship over periods of 5 years or more, and of these two (20%) were significantly positive.  Of the six assessments over 12-59 months, three were significantly positive (50%).

Of four assessments of change in waist circumference in two cohorts, three suggested no significant effect, and one suggested a negative effect (greater fat intake was associated with a smaller change in waist circumference).  One study assessed association of total fat with absolute body weight 10 years later and found a positive association in black men and women, but no association in white men and women.  The final study assessed the relationship between total fat intake and absolute BMI, not adjusting for energy in any way, and found no relationship.  The cohort study with least risk of bias found no association between total fat intake and change in body weight over five years in either men or women.

GRADE assessment.
 GRADE assessment of the evidence in adults relied on the RCT data and suggested high quality evidence of the relationship between total fat intake and body weight (Supplementary Table 9). 

Children’s RCT and cohort data
Four children’s studies were included: 1 RCT and 3 prospective cohorts. All included cohorts were from North America, and the RCT from Greece.  The RCT had a duration of 12 months, and cohort studies had one or two years follow-up. 

As part of the VYRONAS RCT, Mihas (81) randomised 191 students aged 12-13 years at baseline to intervention or usual diet. The intervention group (n=98) had a 12-week school-based health and nutrition interventional programme with a one-year follow-up period. After twelve months, total fat intake (as %E) showed a significant reduction compared with baseline in the intervention group (31.3 (SD 4.4) vs 35.4 (SD 4.7), p<0.001), but not in the control group (36.2 (SD 5.2) vs 36.9 (SD 4.8), p=0.343). Mean BMI (kg/m2) also decreased significantly (adjusting for age and gender) compared with baseline in the intervention group (23.3 (SD 2.8) vs 24.0 (SD 3.1), p<0.001), but remained practically unchanged in the control group (24.8 (SD 3.8) vs 24.3 (SD 3.3), p=0.355).  The difference in weight between intervention and control arms was not reported, but our own analysis (in RevMan) of the outcome data suggests that the effect of a low fat compared to usual fat diet in children was -1.50kg/m2 (95% CI -2.45 to -0.55), however this was assessed on adjusted data and without analysis of the original data set this should be considered with caution.

Validity of this child RCT is summarised in Supplementary Figure 3.  While it appears to have had adequate sequence generation, concealment of allocation, and addressed incomplete outcome data it was not blinded, had systematic differences in care between intervention and control groups, and was encouraging differences in diet between the two arms other than differences in dietary fat.

Risk of bias of the included cohort studies is summarised in Supplementary Table 7.  One study was at moderate risk of bias (82), the other two were at high risk.  All three were funded by non-commercial bodies, all had internal control groups. One failed to adjust for 3 important potential confounders (83) (the others failed to adjust for 1 or 2), one lost more than 20% of its participants during follow up (84).  Two studies assessed dietary intake using 24-hour dietary recall, the other used a food frequency questionnaire.  None of the studies reported baseline similarities of children by total fat intake.   

See Supplementary Table 8 for characteristics of the child cohorts.  For two studies the relationship assessed was between baseline fat %E and BMI change, the other was between baseline fat %E and weight change.  For two studies the relationship was positive and statistically significant, the third was positive and marginally significant (p=0.05).  Klesges (84) also assessed relationships between change in fat %E from baseline to one year, one year to 2 years and baseline to 2 years and BMI change over 2 years.  One of these 3 relationships was positive (the others showed no effect).  








33 RCTs (73,589 participants) and 10 cohort studies of adults, plus 1 RCT and 3 cohort studies of children, were included, all from North America, Europe or New Zealand.  Meta-analysis of adult RCTs suggested that diets lower in total fat lower relative body weight (on average by 1.6kg, 95% CI -2.0 to -1.2kg, I2 75%, 57735 participants), BMI (-0.51 kg/m2, 95% CI -0.76, -0.26, 9 trials, I2 77%) and waist circumference (by 0.3cm, 95% CI -0.58 to -0.02, 15671 women, 1 RCT). These effects were from RCTs in which weight loss was not an intended outcome suggesting that they occur in people eating normal diets, and the direction of effect on weight was consistent regardless of sub-grouping or sensitivity analyses.  Reductions in total fat were associated with small but statistically significant reductions in total, LDL and total/HDL cholesterols, systolic and diastolic blood pressure, suggesting a lack of harm on other major cardiovascular risk factors.  

Meta-regression suggested that greater total fat reduction and lower baseline total fat were associated with greater relative weight loss, in studies with a total fat intake at baseline of between 28 and 43% of energy, but that any reduction in total fat will be reflected in some weight reduction relative to control.  Longer duration was not associated with a reduction in the degree of weight loss in studies with duration of 0.5 to over 8 years (weight data were taken from the latest reported time in each trial, and was at 7 year follow-up for the single largest study, WHI, which included over half the participants of the systematic review).

While further metabolic studies may reveal a mechanism of action, most studies that reported energy intake suggested lower energy intake in the low fat group than the control or usual fat group, and subgrouping suggested that a greater degree of energy reduction in the low fat group (compared to control) was related to greater weight loss. This suggests that weight reduction may be due to reduced energy intake in those on low fat diets, rather than a specific effect of the macronutrient composition of the diet.

Cohort data in adults suggested either no relationship between baseline total fat %E and weight change over one or more years, or a positive relationship (in a third of comparisons).  Given the strength of evidence from RCTs of a consistent effect of reducing total fat on weight the general lack of association found in cohort studies is surprising.  However, this may be due to the relative insensitivity of the instruments used to measure total fat intake (most used food frequency questionnaires or FFQs, two used some form of dietary recall but one of these was a single 24-hour recall, and one used a 7-day weighed intake), the small size of the relationship being sought, and the confounding effect of dieting behaviour that is common in the populations studied. 

The small amount of RCT (1 RCT from Greece, 191 participants) and cohort data (3 cohorts from the US, 1337 participants) in children was confirmatory of a relationship between total fat intake and subsequent weight change.

Strengths and weaknesses 
Strength of evidence is discussed according to the GRADE headings of risk of bias, inconsistency, indirectness, imprecision, and other factors (including dose response) (16). 

Risk of bias: While most adult RCTs were un-blinded and randomisation was rarely well enough described to assess allocation concealment, results from these RCTs were remarkably consistent. Sensitivity analyses removing RCTs without clear allocation concealment did not lose the statistically significant weight loss in the low fat arm, and neither did running fixed (rather than random) effects meta-analysis or removing RCTs with attention bias favouring those in the low fat arm, or those with other interventions alongside the fat reduction. The consistent weight loss was despite the fact that none of the RCTs included intended to alter weight in either arm, and reporting bias appeared unlikely.  Given the consistency and strength of the RCT data in adults, the assessment of effect size and risk of bias for GRADE assessment are based on RCT data alone, and the risk of bias for effects in adults was low.

In children the risk of bias was based on only 1 RCT (191 12-13 year olds) and 3 cohort studies (1337 children aged 3 to 19 years), all with flaws, so that the risk of bias was moderate.  

Inconsistency: The effects in the adult RCTs were remarkably consistent - in almost every RCT participants eating lower total fat intakes were lower in weight (on average) at the study end than participants eating a higher percentage of total fat, or gained less weight or lost more weight. The only inconsistency (where heterogeneity arose) was in the size of this effect. The heterogeneity was partly explained in subgrouping and meta-regression by the degree of reduction of fat intake, and by the level of control group fat intake, together explaining 58% of between-study variance.  The reduction in weight in those on lower fat diets was seen in very different populations and from 6 months to several years. It was still present when RCTs that gave additional support, time or encouragement to the low fat arms were excluded, and where RCTs that delivered additional dietary interventions (on top of the change in dietary fats) were included.  Inconsistency was not considered a problem. 

In children the single RCT and two of three cohort studies suggested that higher total fat intake was associated with higher gain of weight or BMI over 1-2 years.  However, there were insufficient included studies to assess the possibility of small study bias, or to formally assess heterogeneity. 

Indirectness of evidence: All adult and child RCTs directly compared (and randomised participants to) lower vs. higher fat intake, and measured absolute or changes in body fatness outcomes.  There was only indirectness in extrapolating effects to developing or transitional countries. 

Imprecision: Imprecision in adult data was unlikely, as over 14000 participants were included in RCTs of at least 6 months duration, and effect sizes were highly statistically significant.  There was no imprecision for adults, however imprecision was high in child data (although not quantifiable), and pooling was not possible. 

Other factors: there is evidence in adults of a dose response gradient between total fat intake and weight change, and little evidence of publication bias.  In children there were insufficient studies to assess either.  These trials will not be able to reveal mechanisms of action; metabolic studies would be needed for this.

Comparison with other studies
The question of whether dietary fat intake affects weight has been investigated in several non-systematic reviews (85;86), and also some systematic reviews.  Yu-Poth systematically reviewed a very different set of RCTs, including those of only 3 weeks or more duration and some that aimed to reduce weight, including 37 trials and 9276 participants to 1997, and found that for each decrease of 1% of energy from total fat there was a 0.28kg reduction in body weight (5).  Astrup also systematically reviewed RCTs that compared ad libitum low fat diets with usual or moderate fat intake for at least 2 months to 1998 (10).  They included 16 trials randomising 1728 participants for up to 1 year, some of which aimed at weight loss, and found that each reduction of 1%E as total fat resulted in a reduction of 0.37kg.  Trials that assessed very short term effects or aimed to reduce weight in the low fat arms may well have overstated any effect size.  Our review only included unconfounded RCTs of at least 6 months, and excluded all trials that aimed to reduce weight, including 33 RCTs and 73,589 participants.  We found slightly more modest but clear effects on weight, a reduction of 0.19kg (95% CI -0.33 to -0.06) for each 1%E from total fat. We found no systematic reviews that assessed effects in children.

Meaning
Reducing total fat intake in adults appears to cause reductions in weight, BMI and waist circumference compared to those who do not reduce their fat intake.  These relationships appear to hold true in adult studies of over 8 years duration, of baseline total fat intakes of 28 to 43% of energy, and in healthy adults and those with risk factors or current illness, however they have not been tested in low or middle income countries.  While the evidence is slightly less strong in children, diets higher in total fat appear to be associated with higher body weight, BMI and waist circumference in both adults and children than diets lower in fat.  

The health effect for an individual reducing their weight by 1.6kg is likely to be small, but the health effects of a whole population reducing weight on average by 1.6kg would be noticeable.  A systematic review of a large number of cohort studies found that, over a body mass index (BMI) of 25kg/m2 (over 60% of UK adults have a BMI greater than 25) each additional 5kg/m2 was associated with 30% greater total mortality (with contributions from vascular, diabetic, renal, hepatic, neoplastic and respiratory mortalities) (87).  In an 80kg man of average height (1.75m) a loss of 1.6kg will reduce body mass index from 26.12 to 25.60 kg/m2, a reduction of 0.52 kg/m2, which would be associated with a reduction in total mortality of 3%. 

Implications for public health policy are that although reducing total fat intakes may be difficult it should be attempted to help control weight in populations where mean total fat intakes are 30% of energy or higher.  For populations where mean total fat intake is below 30% of energy preventing rises of total fat to intakes greater than 30% of energy may help to prevent increases in obesity.

Implications for research
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